06 Nov 2025

Appear ASA Marks Listing on Euronext Oslo Børs

"CLP advised Appear ASA on its listing on Euronext Oslo Børs. Shares began trading on 6 November 2025 under ticker APR following an IPO that raised approx. NOK 961 million and implied a market cap of ~NOK 2.5 billion. The offering was over 12x oversubscribed and added more than 5,000 new shareholders. ABG Sundal Collier and DNB Carnegie cooperated in the process."

CLP advised Appear ASA in connection with its listing on Euronext Oslo Børs; ABG Sundal Collier and DNB Carnegie acted as cooperating financial partners. On 6 November 2025 Appear ASA marked its first day of listing on Euronext Oslo Børs, where its shares began trading under the ticker symbol APR. Appear designs and delivers high-capacity, sustainable solutions for media processing and live content delivery, empowering broadcasters and operators to capture, transport and process live video and audio from venue to viewer with exceptional quality and reliability. The listing followed an initial public offering comprising both an issuance of new shares and sales of existing shares, which generated gross proceeds of approximately NOK 961 million. The IPO implied a market capitalisation of the company of approximately NOK 2.5 billion. The offering attracted significant interest and was more than twelve times oversubscribed; the company welcomed in excess of 5,000 new shareholders following the IPO. CLP represented Appear ASA with a team composed by: Andreas Kildal, Joakim Gjerde, Max Mossin Wagle and Amalie Sundby.
Read the full story

Register for free to access daily news.

Register Free
We use cookies to improve your experience, analyze traffic, and serve targeted ads. Read our Cookie Policy.

Cookie Preferences

Customize your cookie settings. Necessary cookies are always enabled.

Strictly Necessary

Required for the website to function (e.g. login, security).

Analytics & Statistics

Help us understand how visitors interact with the website.

Marketing & Ads

Used to deliver relevant ads and track effectiveness.